Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Some drugs used to treat immune conditions may cause different types of hair loss.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Some canine hair follicle tumors contain amyloid deposits, with a protein called CK5 involved in their formation.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

CD4+ skin cells may be precursors to basal cell carcinoma.

Analyzing hair proteins can help identify new markers for hair health and aging.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Minor injuries to hair follicles can stimulate hair growth in mice by increasing a specific protein.

Minor skin injuries can boost hair growth by increasing TNF-α.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Hair follicle stem cells may cause squamous cell carcinoma due to a metabolic shift towards glycolysis.

Acer1 is essential for skin health and affects hair growth and skin cancer risk.

B cells can both help and hinder the body's defense against melanoma.